LCN2 and cancer: Having established the differential overexpression in pancreatic cancer, specifically in the PanIN lesions, we next investigated whether the measurement of NGAL levels in the serum could be useful to distinguish pancreatic cancer from non-cancer cases (including, pancreatitis).